Relative to its peers, OGEN does not have very much institutional sponsorship. The 14.13% of shares outstanding held by institutional investors is among the least of any stock in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
IFP ADVISORS, INC. Bought 35.3 Thousand shares of Oragenics Inc
THE VANGUARD GROUP, INC. Bought 12.9 Thousand shares of Oragenics Inc
BLACKROCK FUND ADVISORS Bought 2.8 Thousand shares of Oragenics Inc